Jazz Pharmaceuticals PLC (JAZZ)
Operating profit margin
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating income (ttm) | US$ in thousands | 578,580 | 192,697 | 45,068 | -27,022 | -65,528 | 247,238 | 250,844 | 95,708 | 170,278 | 294,312 | 462,150 | 729,866 | 378,073 | 265,904 | 202,800 | 208,957 | 532,374 | 656,184 | 711,858 | 660,774 |
| Revenue (ttm) | US$ in thousands | 3,809,836 | 3,720,411 | 3,685,651 | 3,662,251 | 3,569,427 | 3,471,828 | 3,371,195 | 3,194,350 | 2,999,693 | 2,864,101 | 2,628,980 | 2,436,329 | 2,361,556 | 2,277,779 | 2,214,357 | 2,184,676 | 2,158,500 | 2,053,217 | 1,985,763 | 1,953,884 |
| Operating profit margin | 15.19% | 5.18% | 1.22% | -0.74% | -1.84% | 7.12% | 7.44% | 3.00% | 5.68% | 10.28% | 17.58% | 29.96% | 16.01% | 11.67% | 9.16% | 9.56% | 24.66% | 31.96% | 35.85% | 33.82% |
December 31, 2023 calculation
Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $578,580K ÷ $3,809,836K
= 15.19%
The operating profit margin for Jazz Pharmaceuticals plc has shown a generally positive trend over the quarters in consideration. The margin has consistently improved from 2.90% in Q1 2022 to 15.59% in Q4 2023. This indicates a consistent growth in the company's ability to generate profits from its core operations relative to its revenue.
The gradual increase in the operating profit margin signifies improved operational efficiency and cost management within the company. Specifically, the margins have shown significant improvement from Q2 2022 onwards, with a notable spike in Q4 2022 to Q1 2023. This may indicate successful cost-cutting measures or enhanced revenue generation strategies implemented by Jazz Pharmaceuticals plc during this period.
Overall, the increasing trend in the operating profit margin is a positive indicator of the company's financial health and profitability, suggesting that Jazz Pharmaceuticals plc is effectively managing its operational costs and generating stronger returns on its revenue as time progresses.
Peer comparison
Dec 31, 2023